Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Read together with the failed fosgonimeton trial, the takeaway is that the human-relevant evidence base for this class is both thin and, where it touched humans, negative
Anemia 2018 , 1456323 (2018)
Initial effort to generate IAP antagonists was aimed at mimicking the four amino-terminal residues of mature active SMAC that binds IAP
Antioxidant activity and protective effect of extract of Celosia cristata L
US$ 22.37
US$ 21.70
US$ 29.59
US$ 27.45
